Microvesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells Enhance Alveolar Type II Cell Proliferation and Attenuate Lung Inflammation in a Rat Model of Bronchopulmonary Dysplasia
Open Access
- 27 June 2022
- journal article
- research article
- Published by Wiley in Stem Cells International
- Vol. 2022, 1-16
Abstract
Although it is known that exosomes derived from human umbilical cord mesenchymal stem cells (hUCMSCs) alleviate hyperoxic lung injury of bronchopulmonary dysplasia (BPD) in animal models, the role of microvesicles (MVs) derived from hUCMSCs in BPD is poorly defined. Furthermore, antenatal inflammation has been linked to high risk of BPD in preterm infants. The purpose of this study was to explore whether MVs derived from hUCMSCs can preserve lung structure and function in an antenatal lipopolysaccharide- (LPS-) induced BPD rat model and to clarify the underlying mechanism. We demonstrate that antenatal LPS induced alveolar simplification, altered lung function, and dysregulated pulmonary vasculature, which restored by hUCMSCs and MVs treatment. Furthermore, MVs were large vesicles with a diameter of 100-900 nanometers and mostly uptaken by alveolar epithelial type II cells (AT2) and macrophages. Compared with the LPS-exposed group, MVs restored the AT2 cell number and SP-C expression in vivo and promoted the proliferation of AT2 cells in vitro. MVs also restored the level of IL-6 and IL-10 in lung homogenate. Additionally, PTEN/AKT and MAPK pathways were associated with the protection of MVs. Taken together, this study suggests MVs derived from hUCMSCs improve lung architecture and function in an antenatal LPS-induced BPD rat model by promoting AT2 cell proliferation and attenuating lung inflammation; thus, MVs provide a promising therapeutic vehicle for BPD treatment.Keywords
All Related Versions
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2016YFA0101301, NCRC-2019-GP-11)
- National Clinical Research Center for Child Health and Disorders (2016YFA0101301, NCRC-2019-GP-11)
This publication has 54 references indexed in Scilit:
- Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasiaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2012
- Exosome Secretion: Molecular Mechanisms and Roles in Immune ResponsesTraffic, 2011
- Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research NetworkPediatrics, 2010
- Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposureJournal of Applied Physiology, 2010
- Fetal Growth Restriction and Chronic Lung Disease Among Infants Born Before the 28th Week of GestationPediatrics, 2009
- The Role of Scgb1a1+ Clara Cells in the Long-Term Maintenance and Repair of Lung Airway, but Not Alveolar, EpitheliumCell Stem Cell, 2009
- Intrauterine Inflammation, Neonatal Sepsis, and Chronic Lung Disease: A 13-Year Hospital Cohort StudyPediatrics, 2009
- Predictors of death or bronchopulmonary dysplasia in preterm infants with respiratory failureJournal of Perinatology, 2008
- The Alabama Preterm Birth Study: Umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infantsAmerican Journal of Obstetrics and Gynecology, 2008
- Biology of alveolar type II cellsRespirology, 2006